Cardiac troponin and COVID-19 severity: Results from BIOCOVID study.

ABSTRACT:

Background

Myocardial injury is a common finding in COVID-19 strongly associated with severity. We analysed the prevalence and prognostic utility of myocardial injury, characterized by elevated cardiac troponin, in a large population of COVID-19 patients, and further evaluated separately the role of troponin T and I.

Methods

This is a multicentre, retrospective observational study enrolling patients with laboratory-confirmed COVID-19 who were hospitalized in 32 Spanish hospitals. Elevated troponin levels were defined as values above the sex-specific 99th percentile upper reference limit, as recommended by international guidelines. Thirty-day mortality was defined as endpoint.

Results

A total of 1280 COVID-19 patients were included in this study, of whom 187 (14.6%) di

SUBMITTER: Garcia de Guadiana-Romualdo L 

PROVIDER: S-EPMC7995181 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature